Literature DB >> 7564079

The hemolytic uremic syndrome.

G Remuzzi1, P Ruggenenti.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7564079     DOI： 10.1038/ki.1995.261

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  26 in total

Review 1.  Drug-induced thrombotic microangiopathy: incidence, prevention and management.

Authors:  R Pisoni; P Ruggenenti; G Remuzzi
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

2.  Shiga toxin-1 affects nitric oxide production by human glomerular endothelial and mesangial cells.

Authors:  D Maroeska Te Loo; Leo Monnens; Thea van der Velden; Mohammed Karmali; Lambertus van den Heuvel; Victor van Hinsbergh
Journal:  Pediatr Nephrol       Date:  2006-08-30       Impact factor: 3.714

3.  Activation of the Akt-NF-kappaB pathway by subtilase cytotoxin through the ATF6 branch of the unfolded protein response.

Authors:  Hiroaki Yamazaki; Nobuhiko Hiramatsu; Kunihiro Hayakawa; Yasuhiro Tagawa; Maro Okamura; Ryouji Ogata; Tao Huang; Shotaro Nakajima; Jian Yao; Adrienne W Paton; James C Paton; Masanori Kitamura
Journal:  J Immunol       Date:  2009-06-26       Impact factor: 5.422

4.  Control of enterohaemorrhagic Escherichia coli infection: the need for a network involving microbiological laboratories and clinical and public health institutions.

Authors:  H Karch
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-04       Impact factor: 3.267

5.  Thrombotic microangiopathy in the HIV-2-infected macaque.

Authors:  F Eitner; Y Cui; K L Hudkins; A Schmidt; T Birkebak; M B Agy; S L Hu; W R Morton; D M Anderson; C E Alpers
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

Review 6.  Thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS): the new thinking.

Authors:  J Liu; M Hutzler; C Li; L Pechet
Journal:  J Thromb Thrombolysis       Date:  2001-05       Impact factor: 2.300

7.  [A 32-year-old patient with diarrhoea and acute kidney failure].

Authors:  A Hoffmeister; H Wittenburg; N Teich; A Bachmann; G Borte; J Mössner; H Achenbach
Journal:  Internist (Berl)       Date:  2006-10       Impact factor: 0.743

Review 8.  [Therapeutic plasma exchange 1996].

Authors:  U Weber; W Riegel; H Köhler
Journal:  Med Klin (Munich)       Date:  1997-10-15

9.  Risk factors for poor renal prognosis in children with hemolytic uremic syndrome.

Authors:  Alessandra Gianviti; Alberto E Tozzi; Laura De Petris; Alfredo Caprioli; Lucilla Ravà; Alberto Edefonti; Gianluigi Ardissino; Giovanni Montini; Graziella Zacchello; Alfonso Ferretti; Carmine Pecoraro; Tommaso De Palo; Angela Caringella; Maurizio Gaido; Rosanna Coppo; Francesco Perfumo; Nunzia Miglietti; Ilse Ratsche; Rosa Penza; Giovambattista Capasso; Silvio Maringhini; Salvatore Li Volti; Carmen Setzu; Marco Pennesi; Alberto Bettinelli; Leopoldo Peratoner; Ivana Pela; Elio Salvaggio; Giuliana Lama; Salvatore Maffei; Gianfranco Rizzoni
Journal:  Pediatr Nephrol       Date:  2003-10-31       Impact factor: 3.714

10.  Verocytotoxin-producing Escherichia coli infection in hemolytic uremic syndrome in part of western Europe.

Authors:  N C van de Kar; H G Roelofs; H L Muytjens; J J Tolboom; B Roth; W Proesmans; W C Reitsma-Bierens; E D Wolff; M A Karmali; H Chart; L A Monnens
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.